TotalMarketCap

Cytek Biosciences

CTKBNasdaq United StatesIndustrialsBiotechnology: Laboratory Analytical Instruments

Market cap

$704.272 M

$5.39 -8.42%

Close of 6 Nov 2026

As of 6 Nov 2026, Cytek Biosciences (CTKB) has a market capitalization of $704.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$201.5M

#2268 by revenue

Earnings

-$66.5M

Loss-making

Shares outstanding

130,783,967

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →
  1. #9Alamar BiosciencesALMR$1.88B
  2. #10Pacific Biosciences Of CaliforniaPACB$756.9M
  3. #11Cytek BiosciencesCTKB$704.3M
  4. #12Nautilus BiotechnologyNAUT$277.0M
  5. #13Standard BiotoolsLAB$245.3M

What if Cytek Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$215,904.71

Per share 40,094× higher

Bitcoin $1.53T

$11,682.23

Per share 2,169× higher

Apple $5.02T

$38,351.66

Per share 7,122× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Cytek Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.